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Abstract
Renal stones disease is one of the most prevalent diseases encountered in the practice of urology.
This study described how patients with ureteric stones are managed in the main referral hospital in
Palestine. Another aim was to investigate associations between sociodemographic and clinical variables of the patients with the interventions and medications prescribed to manage patients with ureteric stones. Medical and surgical records of patients admitted to the hospital for ureteric stones were
reviewed, and relevant data were extracted using a data collection form created for this study. The
data extraction form collected the patient's age, gender, comorbidities, interventional procedures, and
main laboratory findings like serum creatinine and blood urea nitrogen levels. The final analysis
included the complete medical and surgical records of 143 patients in this study. The median age of
the patients included was 43.0 [29.0, 55.0] years, the median blood urea nitrogen was 13.8 [10.6,
17.3] mg/dL, and the median serum creatinine was 0.96 [0.75, 1.25] mg/dL. Most patients (79.0%)
had a double J stent, and 33 (23.1%) had laser lithotripsy. More than half of the patients (60.8%)
received ciprofloxacin. Age had significant and positive moderate correlation with blood urea nitrogen (Spearman’s rho = 0.37, p-value < 0.001) and serum creatinine (Spearman’s rho = 0.28, p-value
= 0.002) levels. Younger age was associated with placement of double J stents patients (Chi-square
= 5.1, p-value = 0.039). Placement of double J stent was associated with reporting right or left flanking pain (Chi-square = 16.0, p-value = 0.001). Prescription of ciprofloxacin was associated with
prescription of diclofenac sodium (Chi-square = 28.3, p-value < 0.001). In conclusion, patients with
ureteric stones were adequately managed using different techniques in a large Palestinian referral
hospital. Future studies are still needed to describe how patients with other renal stones are managed
in Palestinian urology practice.
Keywords: Ureteric Stones, Renal Stones, Creatinine, Retrospective Study, Urology.
INTRODUCTION
Renal stones, also known as kidney
stones, renal calculi, urolithiasis, or nephrolithiasis, are hard deposits of minerals and
salts within the kidneys (1). This disease is
one of the most prevalent diseases encountered in the practice of urology (2). The leading cause of renal stones is the supersaturation
of urine with minerals and salts that deposit
and solidify into stones within the renal tract.
Notably, the solubility of minerals and salts
within the renal system is affected by many
factors, including volume of urine, pH, and total excretion of solutes (3).

Stones are often classified based on their
composition. Of all stones, calcium oxalate
stones are the most prevalent form. Calcium
phosphate and oxalate stones account for approximately 75% of all stones (4). Stones are
also formed from uric acid, magnesium ammonium phosphate, and cysteine. Predisposing risk factors include male gender, ethnicity,
living in hot areas, increased intake of salt and
animal proteins, diabetes mellitus, hypertension, obesity, metabolic syndrome, gout, hyperparathyroidism, sarcoidosis, Crohn's disease, renal tubular acidosis, idiopathic hypercalciuria, and homocystinuria (5, 6). Current
recommendations to reduce the formation of
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renal stones include mitigating risk factors
like decreasing salt and protein intake and increasing water, fruit, and fiber intake (7).
Previous studies have shown that the
prevalence of renal stones varied depending
on the climate and population studied. In the
United States, renal stones affect approximately 5% of adults (1). A study in King Abdulaziz University Hospital, Saudi Arabia,
showed that renal stones were prevalent in
16.9% of 1031 patients (3). Another more extensive study by Ahmad et al. included participants from 30 nationalities who worked in
Saudi Arabia (8). The study showed that renal
stones were prevalent among 19.16% of the
5371 participants (8, 9). Of the stones, 73.3%
were renal stones, 13% were ureteric stones,
9.8% were in the vesicoureteric junction,
2.3% were in the pelvic ureteric junction, and
1.1% were in the bladder, and 0.5% were urethral stones (8). The study showed that renal
stones' prevalence varied among participants
of different nationalities, higher among Egyptians (29.5%) and Pakistanis (24.9%).
Patients with renal stones often have
flank pain, renal colic, hematuria, obstructive
uropathy, urinary tract infections, and hydronephrosis (10, 11). Signs and symptoms vary
depending on the site and size of the stone. Patients may also present with dysuria, frequency, and urgency (12). In acute stone
events, nausea and vomiting might also be
noted (5, 13, 14). Although patients with renal
stones often present with one or a combination
of the typical signs and symptoms, incidental
detection of renal stones was also reported using CT scans (15).
Patients with suspected renal stones are
investigated using urinalysis to detect potential hypercalciuria, hyperoxaluria, urine pH,
and white blood cells (16). In the emergency
department, a CT scan without contrast is the
gold standard for diagnosing renal stones in
patients with flank pain. Other imaging modalities include pelvic X-ray, kidneys-uretersbladder radiography, ultrasound, and magnetic resonance imaging (17).
Currently, little is known about how ureteric kidney patients are managed in Palestinian urology practice. This study described
how patients with ureteric stones are managed
in the main referral hospital in Palestine.

Additionally, the study aimed to investigate
associations between sociodemographic and
clinical variables of the patients with the interventions done and medications prescribed to
manage patients with ureteric stones.
METHODS
Study settings and design
This study was conducted in a cross-sectional retrospective design in one of the leading referral hospitals in Palestine. The hospital
is located on the West Bank. The hospital provides healthcare services through different departments, including urology.
Sampling and data collection procedures
Because ureteric stones are common
among Palestinians (2), more than 20,000 patients should have been managed in the Palestinian urology practice. We calculated the
sample size at a 90% confidence interval (90%
CI) and accepted a margin of error of 0.05.
The sample size was estimated for the largest
population. Based on previous studies, we assumed a prevalence rate of ureteric stones at
12%. Therefore, a population proportion of
12% was used. We used an online sample size
calculator (raosoft.com/samplesize.html) to
calculate the sample size needed for this study
(18). The sample size needed for this study
was 115 patients.
Medical and surgical records of patients
admitted to the hospital for ureteric stones
were reviewed, and relevant data were extracted using a data collection form created for
this study. The data extraction form collected
the patient's age, gender, comorbidities, interventional procedures, and central laboratory
findings like serum creatinine and blood urea
nitrogen levels.
The electronic health records were
searched for patients admitted with a ureteric
stone diagnosis from 2016-to 2021. Different
keywords were used to search the electronic
system to ensure retrieval of all records. These
keywords included all possible variations related to "ureteric stone", "endoscopic doubleJ ureteric stent", "endoscopy double-J stent",
"one side ureteric stone", "middle ureteric
stone", "upper ureteric stone", "ureteric stone
large volume", "ureteric stone small volume",
"ureteroscopy rigid", and "flexible with laser
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fragmentation". The keywords were searched
both individually and collectively. Patient/file
identification/serial numbers were used to retrieve medical and surgical records.
Statistical analysis
The data collected in this study were
coded and entered into IBM SPSS for Windows v.21.0. The data were assessed for normality of distribution using the Kolmogorov–
Smirnov test. As the data were not normally
distributed, non-parametric tests were used to
analyze the data. Continuous data were presented as median [lower quartile (Q1), upper
quartile (Q3)], and categorical data were presented as numbers (percentages). In this study,
correlations were assessed using Spearman's
rank correlations. Associations were investigated using Chi-square/Fisher's exact tests. A
p-value of < 0.05 indicated statistical significance.
RESULTS
Characteristics of the study patients
In this study, the complete medical and
surgical records of 143 patients were selected.
The median age of the patients included was
43.0 [29.0, 55.0] years, the median blood urea
nitrogen was 13.8 [10.6, 17.3] mg/dL, and the
median serum creatinine was 0.96 [0.75, 1.25]
mg/dL. Of the patients included, 107 (74.8%)
were male, 133 (93.0%) had no known allergy, 62 (43.4%0 had left ureteric stone, 55
(38.5%) complained from left flank pain, 86
(60.1%0 had pre-existing comorbidities, 17
(11.9%) had blood urea nitrogen of 20 mg/dL
or more, and 19 (13.3%) had serum creatinine
level of 1.35 mg/dL or more. Details of the sociodemographic and clinical characteristics of
the patients are shown in (Table 1).
Table (1): Demographic and clinical characteristics of the patients (n = 143).
Characteristic
Age (years)
< 43
≥ 43
Gender
Male
Female
Having a known allergy
Yes
No

n

%

69
74

48.3
51.7

107
36

74.8
25.2

10
133

7.0
93.0

Characteristic
n
Diagnosis
Right ureteric stone
55
Left ureteric stone
62
Bilateral ureteric stone
12
Other
14
Chief complaint
Right flank pain
51
Left flank pain
55
Bilateral pain
6
Other descriptions of
31
pain
Presence of known
comorbidities
Yes
86
No
57
Blood urea nitrogen (mg/dL)
< 20
126
≥ 20
17
Serum creatinine (mg/dL)
< 1.35
124
≥ 1.35
19

%
38.5
43.4
8.4
9.8
35.7
38.5
4.2
21.7

60.1
39.9
88.1
11.9
86.7
13.3

Interventions and medications prescribed for
the study patients
The majority of the patients (79.0%) had
a double J stent placed, 1 (0.7%) had nephrostomy, 22 (15.4%) had their stents removed, 11
(7.7%) had retrograde pyelogram, 2 (1.4%)
had fluoroscopy, and 33 (23.1%) had laser
lithotripsy. Details of the interventions made
in this study are shown in (Table 2).
Table (2): Interventions made in this study
Intervention
Double J stent
Nephrostomy
Stent removal
Retrograde pyelogram
Fluoroscopy
Laser lithotripsy

n
113
1
22
11
2
33

%
79.0
0.7
15.4
7.7
1.4
23.1

More than half of the patients (60.8%) received ciprofloxacin, 13 (9.1%) received
levofloxacin, 15 (10.5%) received cefuroxime, 2 (1.4%) received ceftriaxone, 5 (3.5%)
received cefixime, 61 (42.7%) received paracetamol, 65 (45.5%) received diclofenac sodium, 2 (1.4%) received captopril, 13 (9.1%)
received tamsulosin, 6 (4.2%) received bendamustine, 2 (1.4%) received potassium citrate,
and 8 (5.6%) received esomeprazole. Details
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of the medications prescribed for the study patients are shown in (Table 3).
Table (3): Medications prescribed for the
study patients.
Medication
Ciprofloxacin
Levofloxacin
Cefuroxime
Ceftriaxone
Cefixime
Paracetamol
Diclofenac sodium
Captopril
Tamsulosin
Bendamustine
Potassium citrate
Esomeprazole

n
87
13
15
2
5
61
65
2
13
6
2
8

%
60.8
9.1
10.5
1.4
3.5
42.7
45.5
1.4
9.1
4.2
1.4
5.6

Associations between variables of the patients, interventions, and treatments
Age had significant and positive moderate correlation with blood urea nitrogen
(Spearman’s rho = 0.37, p-value < 0.001) and
serum creatinine (Spearman’s rho = 0.28, pvalue = 0.002) levels. There was a significant
positive strong correlation between blood urea
nitrogen and serum creatinine levels (Spearman’s rho = 0.63, p-value < 0.001).
Older age was associated with presence
of known comorbidities (Chi-square = 10.6, pvalue = 0.001). On the other hand, younger
age was associated with placement of DJ
stents (Chi-square = 5.1, p-value = 0.039) and
prescription of cefuroxime (Chi-square = 6.8,
p-value = 0.013). Male gender was associated
with serum creatinine higher than 1.35 mg/dL
(Chi-square = 7.4, p-value = 0.008) and prescription of tamsulosin (Chi-square = 4.8, pvalue = 0.039).
Patients who had right ureteric stone
complained from right flanking pain and patients who had left ureteric stone complained
from left flanking pain (Chi-square = 168.0, pvalue < 0.001). Placement of double J stent
was associated with reporting right or left
flanking pain (Chi-square = 16.0, p-value =
0.001). Blood urea nitrogen of 20 mg/dL and
more was associated with prescription of captopril (Chi-square = 15.0, p-value = 0.013).
Removal of double J stent was associated with
prescription of bendamustine (Chi-square =

5.8, p-value = 0.047). Similarly, having retrograde pyelogram was associated with prescription of bendamustine (Chi-square = 15.8,
p-value = 0.006).
Prescription of ciprofloxacin was associated with prescription of diclofenac sodium
(Chi-square = 28.3, p-value < 0.001). Patients
who received ciprofloxacin were less likely to
receive other antibiotics like levofloxacin
(Chi-square = 22.2, p-value < 0.001), cefuroxime (Chi-square = 26.0, p-value < 0.001), and
cefixime (Chi-square = 8.0, p-value = 0.008).
Similarly, patients who received ciprofloxacin
were less likely to receive paracetamol (Chisquare = 14.8, p-value < 0.001), and bendamustine (Chi-square = 9.7, p-value = 0.003).
Prescription of levofloxacin was associated
with prescription of esomeprazole (Chisquare = 8.3, p-value = 0.025). Prescription of
cefuroxime was associated with prescription
of captopril (Chi-square = 17.3, p-value =
0.010). Patients who received cefuroxime
were less likely to receive diclofenac sodium
(Chi-square = 7.0, p-value = 0.012) and patients who received paracetamol were less
likely to receive diclofenac sodium (Chisquare = 59.6, p-value < 0.001).
DISCUSSION
Renal stones are a joint presentation in
urology practice (2). This study reviewed
medical and surgical records of patients presenting with ureteric stones to one of the leading referral hospitals in Palestine. This was the
first study to describe how patients with ureteric stones were managed in a Palestinian
hospital to the best of our knowledge. Moreover, this study established associations between variables of the patients with the interventions and medications prescribed to manage their condition. The findings of this study
might be informative to peer clinicians interested in gaining insight into how patients with
ureteric stones are managed in one of the leading referral hospitals in Palestine. Additionally, the findings of this study might be informative to decision-makers who might be
interested in improving patient experiences
and outcomes in urology practice in Palestine.
In this study, the sample of patients was
predominantly of the male gender. The findings of this study were consistent with previous studies that showed that male patients
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were at higher risk for developing renal stones
than female patients (5, 6, 19). More extensive
studies in Saudi Arabia, Korea, and Northern
Ireland showed gender disparity in the prevalence rates of renal stones (3, 19-21). These
studies showed that male patients were 2-3fold more likely to develop renal stones than
female patients. 9.1% of the patients were on
tamsulosin for benign prostatic hyperplasia in
this study. The findings of this study were
consistent with those reported in a retrospective study in Korea in which 9.1% of male patients had a renal stone with benign prostatic
hyperplasia as a comorbidity (21). These results might indicate a higher need for mitigating risk factors among men.
There was a positive correlation between
age, blood urea nitrogen, and serum creatinine
levels among the patients in this study. These
findings were not surprising as the advancement of age was associated with a higher prevalence of diseases like hypertension, diabetes
mellitus, and benign prostatic hyperplasia (21,
22). In Saudi Arabia, advancement of age was
positively correlated with the prevalence of
renal stones among residents of Makkah (23).
In this study, receiving tamsulosin for benign
prostatic hyperplasia was associated with advanced age.
Placement of double J stents was the most
common intervention, and nephrostomy was
the least common intervention performed on
the patients included in this study. Studies
have shown that double J stents and percutaneous nephrostomy had very high success
rates (24). Since Finney's first description of
the double J stents in 1978, ureteral stenting
has become one of the most frequent interventions in urological practice (25, 26). Ureteral
stents are commonly used to facilitate drainage of the upper urinary tract. In this study,
younger age was associated with the placement of double J stents. Although double J
stenting was frequently reported in managing
obstructive uropathies, many studies have
shown that percutaneous nephrostomy could
be a safer and superior method in temporary
urinary diversion (27, 28). Previous studies
have shown that the placement of double J
stents caused discomfort and reduced the patients' quality of life (29). The findings of this
study were consistent with those reportedly
practiced elsewhere in the world (27, 28). In

this study, complaining of right or left flanking pain was associated with the placement of
double J stents. The findings of this study
were consistent with those reportedly practiced elsewhere in the world (27, 28). Results
of this study might indicate that clinicians
need to adhere to the recent guidelines in
choosing the safer and optimal treatment modality for patients with ureteric stones.
In this study, patients have been prescribed fluoroquinolone antibiotics (ciprofloxacin and levofloxacin) and cephalosporin
antibiotics (cefuroxime, ceftriaxone, and
cefixime). Additionally, the patients also received analgesics (paracetamol and diclofenac
sodium). The patients were prescribed the proton pump inhibitor esomeprazole to reduce
gastric discomfort with certain medications.
Our findings indicated appropriate prescribing
behavior (30, 31).
The findings of this study should be interpreted considering several strengths and limitations. First, this was the first study to describe how patients with ureteric stones are
managed in the main referral hospital in Palestine and to investigate associations between
sociodemographic and clinical variables of the
patients with the interventions done and medications prescribed to manage patients with
ureteric stones. Second, a data extraction form
was specifically created to collect the primary
data from the medical and surgical records of
the patients. Third, all complete medical and
surgical records of the patients admitted for
ureteric stones were included in this analysis.
Fourth, the sample size was adequate for this
study design. Fifth, appropriate statistical
analyses were used to analyze and facilitate
interpreting the data. Finally, the study adhered to the STROBE checklist.
This study also had several limitations.
First, this was a retrospective study. Compared to prospective, comparative, and/or interventional studies, retrospective analysis is
limited by design. Second, the data collected
in this study were obtained from the medical
and surgical records of the patients. In this
study, we did not collect blood samples or interview the patients to collect their sociodemographic data. Third, the data collected in this
study was limited to patients with ureteric
stones. Including patients with another type of
renal stone could have provided more
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comprehensive findings. Fourth, this was a
single-center study. A more extensive multicenter study should have reported more reliable experience managing ureteric stones in
Palestinian hospitals. Finally, the data analyzed in this study were collected from the primary referral private hospital. Treatment modalities could vary between private and governmental hospitals in Palestine. Including patients from governmental and private hospitals
should have provided a more comprehensive
experience for patients with ureteric stones in
Palestine.
CONCLUSION
In conclusion, using various procedures,
patients with ureteric stones were satisfactorily handled in a big Palestinian referral hospital. Medication prescriptions were also sufficient. Age, blood urea nitrogen, and serum
creatinine levels had a favorable relationship.
The presence of a double J was connected with
younger age. Future research must detail how
patients with additional renal stones are
treated in Palestinian urological practice.
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